Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions.

Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions.

BACKGROUND: Early clinical studies demonstrated the feasibility of local paclitaxel delivery in reducing restenosis after treatment of de novo coronary lesions in small patient populations. METHODS AND RESULTS: We conducted a randomized, double-blind trial of 536 patients at 38 medical centers eval...

Full description

Bibliographic Details
Main Authors:	Colombo, A, Drzewiecki, J, Banning, A, Grube, E, Hauptmann, K, Silber, S, Dudek, D, Fort, S, Schiele, F, Zmudka, K, Guagliumi, G, Russell, M
Format:	Journal article
Language:	English
Published:	2003

Similar Items

Final 5-year results of the TAXUS II trial: a randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for de novo coronary artery lesions.
by: Silber, S, et al.
Published: (2009)

Safety and efficacy of multiple, overlapping polymer-based paclitaxel-eluting stents.
by: Dawkins, K, et al.
Published: (2007)

TAXUS VI final 5-year results: a multicentre, randomised trial comparing polymer-based moderate-release paclitaxel-eluting stent with a bare metal stent for treatment of long, complex coronary artery lesions.
by: Grube, E, et al.
Published: (2009)

Peristent remodeling and neointimal suppression 2 years after polymer-based, paclitaxel-eluting stent implantation: insights from serial intravascular ultrasound analysis in the TAXUS II study.
by: Aoki, J, et al.
Published: (2005)

Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: insights from the randomized TAXUS II trial.
by: Tanabe, K, et al.
Published: (2005)

Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice.
by: Dawkins, K, et al.
Published: (2005)

TAXUS VI 2-year follow-up: randomized comparison of polymer-based paclitaxel-eluting with bare metal stents for treatment of long, complex lesions.
by: Grube, E, et al.
Published: (2007)

Use of a sirolimus-eluting stent to treat failure of a nonpolymer release paclitaxel-eluting stent implanted for in-stent restenosis.
by: Porto, I, et al.
Published: (2005)

Influence of Elongation of Paclitaxel-Eluting Electrospun-Produced Stent Coating on Paclitaxel Release and Transport through the Arterial Wall after Stenting
by: Zhanna K. Nazarkina, et al.
Published: (2021-04-01)

A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
by: Hang Ouyang, et al.
Published: (2021-04-01)

Two-year serial coronary angiographic and intravascular ultrasound analysis of in-stent angiographic late lumen loss and ultrasonic neointimal volume from the TAXUS II trial.
by: Tsuchida, K, et al.
Published: (2007)

Prophylactic paclitaxel-eluting stent placement does not improve covered femoropopliteal stent patency
by: Rory Marples, MBBS, et al.
Published: (2022-01-01)

Clinical outcomes of second-generation limus-eluting stents compared to paclitaxel-eluting stents for acute myocardial infarction with cardiogenic shock.
by: Chun-Tai Mao, et al.
Published: (2019-01-01)

Use of Paclitaxel Eluting Stents in Arteriovenous Fistulas: A Pilot Study
by: Krystal Dinh, et al.
Published: (2019-12-01)

Impact of Paclitaxel-Eluting Balloons Compared to Second-Generation Drug-Eluting Stents for of In-Stent Restenosis in a Primarily Acute Coronary Syndrome Population
by: Guillaume Marquis-Gravel, et al.
Published: (2017-09-01)

A randomized multicentre study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: The BELLO (Balloon Elution and Late Loss Optimization) study
by: Suraj Khanal
Published: (2013-03-01)

Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents.
by: Banning, A, et al.
Published: (2010)

THE EFFECTS OF CLINICAL, LABORATORY, AND ANGIOGRAPHIC FACTORS ON STENT THROMBOSIS AND MAJOR ADVERSE CARDIAC EVENTS IN PACLITAXEL ELUTING STENTS
by: Kandemir Caglayan Hasan, et al.
Published: (2023-05-01)

Critical evaluation of stents in the peripheral arterial disease of the superficial femoral artery – focus on the paclitaxel eluting stent
by: Litsky J, et al.
Published: (2014-05-01)

Head-to-head comparison of sirolimus-eluting stents versus paclitaxel-eluting stents in patients undergoing percutaneous coronary intervention: a meta-analysis of 76 studies.
by: Xinlin Zhang, et al.
Published: (2014-01-01)

High pressure post-dilatation is necessary to optimize deployment of drug-eluting stents for the treatment of in-stent restenosis
by: Blackman, D, et al.
Published: (2003)

Drug eluting stents: Focus on Cypher™ sirolimus-eluting coronary stents in the treatment of patients with bifurcation lesions
by: Alaide Chieffo, et al.
Published: (2007-09-01)

Thrombotic occlusion of a drug-eluting stent - is IVUS mandatory.
by: Arnold, JR, et al.
Published: (2006)

An Overview of In Vitro Drug Release Methods for Drug-Eluting Stents
by: Navideh Abbasnezhad, et al.
Published: (2022-07-01)

Calcified nodule progression-related stent thrombosis after polymer-based paclitaxel-eluting nitinol stent implantation for femoropopliteal artery
by: Tatsuya Nakama, MD, et al.
Published: (2021-09-01)

The effect of paclitaxel-eluting covered metal stents versus covered metal stents in a rabbit esophageal squamous carcinoma model.
by: Yin Zhang, et al.
Published: (2017-01-01)

Trombose coronariana tardia secundária a implante de stent com paclitaxel sem reestenose dos stents convencionais Late coronary thrombosis secondary to implantation of paclitaxel-eluting stent without restenosis of conventional stents
by: Luciano Maurício de Abreu, et al.
Published: (2007-05-01)

Safety of MRI early after implantation of a drug-eluting stent.
by: Porto, I, et al.
Published: (2004)

Paclitaxel Drug-eluting Tracheal Stent Could Reduce Granulation Tissue Formation in a Canine Model
by: Ting Wang, et al.
Published: (2016-01-01)

Aneurysmal degeneration of fluoropolymer-coated paclitaxel-eluting stent in the superficial femoral artery: a rising concern
by: Takuya Tsujimura, et al.
Published: (2021-07-01)

Usefulness of high-pressure post-dilatation to optimize deployment of drug-eluting stents for the treatment of diffuse in-stent coronary restenosis.
by: Blackman, D, et al.
Published: (2004)

Intravascular ultrasound imaging in the diagnosis and treatment of spontaneous coronary dissection with drug-eluting stents.
by: Porto, I, et al.
Published: (2004)

Which patients receiving warfarin can be treated safely with a drug-eluting stent?
by: Ryding, A, et al.
Published: (2008)

Late stent thrombosis 28 months post implantation of a left main coronary drug-eluting stent.
by: Schrale, R, et al.
Published: (2007)

Drug-Eluting Stent Thrombosis: An oversensationalized but unresolved problem?
by: Azeem Latib, et al.
Published: (2016-02-01)

Efficacy of Sirolimus-Eluting Stents Compared With Paclitaxel-Eluting Stents in an Unselected Population With Coronary Artery Disease: 24-Month Outcomes of Patients in a Prospective Non-randomized Registry in Southern Turkey
by: Davran Çiçek, Hasan Pekdemir, Nihat Kalay, Süleyman Binici, Hakan Altay, Haldun Müderrisoğlu
Published: (2010-01-01)

Patient profile and periprocedural outcomes of bioresorbable vascular scaffold implantation in comparison with drug-eluting and bare-metal stent implantation. Experience from ORPKI Polish National Registry 2014–2015
by: Łukasz Rzeszutko, et al.
Published: (2016-11-01)

An exploratory research on antitumor effect of drug-eluting slow-releasing electrospinning membranes
by: Li Li, et al.
Published: (2023-10-01)

Use of a fluoropolymer-based paclitaxel-eluting stent for arteriovenous graft outflow vein stenosis in hemodialysis patients
by: Yuki Matsuoka, MD, MBA, et al.
Published: (2021-06-01)

Implantation of the paclitaxel-eluting stent Apollo in patients with stable angina pectoris: Long-term angiographic and clinical results
by: T A Batyraliev, et al.
Published: (2010-08-01)